Results 331 to 340 of about 387,179 (386)

Therapeutic efficacy of .BETA.-lactam and aminoglycoside antibiotics on experimental pneumonia caused by Klebsiella pneumoniae B-54 in diabetic mice.

, 1985
Y Obana, Takeshi Nishino, Teruo Tanino
openalex   +2 more sources

Harnessing Molecular and Bioactivity Network Analysis to Prioritize Antibacterial Compound Isolation From Ant‐Associated Fungi

Phytochemical Analysis, Volume 36, Issue 5, Page 1351-1366, July 2025.
ABSTRACT Introduction Antimicrobial resistance is a global public health problem that requires the development of new bioactive compounds. In this context, metabolomic analyses can expedite the research of fungal metabolites as a valuable resource. Objectives To investigate the metabolic profiles and isolate antibacterial compounds from micromycetes ...
Ángel S. Aguilar‐Colorado, Jesús Morales‐Jiménez, José Rivera‐Chávez   +2 more
wiley   +1 more source

Antimicrobial resistance and molecular epidemiology of Klebsiella pneumoniae isolated from bovine mastitis in seven provinces in China. [PDF]

BMC Microbiol
Wang J, Li J, Ji X, Zhang L, Wang R, Wang H, He T.   +6 more
europepmc   +1 more source

Necrotizing Pneumonia Mimicking Lung Tumour: A Case Report

Respirology Case Reports, Volume 13, Issue 7, July 2025.
This case report describes a male patient with necrotizing pneumonia mimicking a lung tumour and highlights the importance of accurate and timely diagnosis in managing necrotizing pneumonia, particularly when it mimics malignancy. ABSTRACT Necrotizing pneumonia, a rare but severe complication of community‐acquired pneumonia, can mimic lung tumours ...
Rahel Yuana Sadikim, Isnin Anang Marhana, Herley Windo Setiawan   +2 more
wiley   +1 more source

Plasma polymeric immunoglobulin receptor exacerbates lung injury in <i>Klebsiella pneumoniae</i>-induced pneumosepsis. [PDF]

Front Immunol
Wang S, Fu H, Li X, Xu H, Bai Y, Jiang W, Cheng X, Chen N, Zhang Y, Li W.   +9 more
europepmc   +1 more source

Secondary Organising Pneumonia Among Immunocompromised Multiple Sclerosis Patients Treated With Ocrelizumab Following COVID‐19 Infection: Two Case Reports With Literature Review

Respirology Case Reports, Volume 13, Issue 7, July 2025.
We describe two cases of biopsy‐proven secondary OP in ocrelizumab‐treated MS patients occurring several weeks after contracting COVID‐19 infection. These patients had been on ocrelizumab for 6.5 years (latent period) before the development of OP. Withdrawal of ocrelizumab and corticosteroids resulted in clinical and radiographic recovery.
Tarake M. Aljarod, Richard Scott Morehead   +1 more
wiley   +1 more source

Phage therapy for Klebsiella pneumoniae: Understanding bacteria-phage interactions for therapeutic innovations. [PDF]

PLoS Pathog
Le Bris J, Chen N, Supandy A, Rendueles O, Van Tyne D.   +4 more
europepmc   +1 more source

Design Principles of Nanosensors for Multiplex Detection of Contaminants in Food

Small, Volume 21, Issue 26, July 3, 2025.
This review discusses recent advancements in nanoparticle‐based nanosensors for multiplex detection of food contaminants, focusing on toxins and pathogens. It highlights the design principles, sensitivity, and selectivity of these sensors, offering insights into their practical applications for food safety monitoring and inspiring future innovations ...
Yang Zhang, Shipeng Gao, Haoran Li, Tianxi Yang, Kaiyi Zheng, Zhing Ming Guo, Jiyong Shi, Xiaowei Huang, Xiaobo Zou, Pierre Picchetti, Frank Biedermann   +10 more
wiley   +1 more source

Metastatic infection of hypervirulent Klebsiella pneumoniae. [PDF]

IDCases
Zhang B, Liu C, Tang Y, Russo TA, Lu M.
europepmc   +1 more source